Table 1.
Comparisons of Clinical Characteristics Between NIPPVPAP and Non‐PAP Groups
| PAP, n = 31 | Non‐PAP, n = 78 | P Value | |
|---|---|---|---|
| Age, y | 65.7 ± 11.7 | 68.5 ± 14.2 | 0.324 |
| Male sex | 23 (74.2) | 46 (59.0) | 0.137 |
| NYHA functional class (I/II/III/IV) | 0/20/11/0 | 0/47/28/3 | 0.533 |
| Epworth Sleepiness Scale | 7.1 ± 4.4 | 5.2 ± 3.7 | 0.085 |
| BMI, kg/m2 | 26.0 ± 4.3 | 23.7 ± 3.9 | 0.010 |
| Ischemic etiology | 5 (16.1) | 9 (11.5) | 0.518 |
| Hypertension | 26 (83.9) | 62 (79.5) | 0.601 |
| DM | 10 (32.3) | 27 (34.6) | 0.815 |
| Dyslipidemia | 26 (83.9) | 62 (79.5) | 0.601 |
| AF | 12 (38.7) | 36 (46.2) | 0.480 |
| CKD | 15 (48.4) | 49 (62.8) | 0.167 |
| Anemia | 8 (25.8) | 39 (50.0) | 0.021 |
| COPD | 8 (25.8) | 22 (28.2) | 0.800 |
| NIPPVPAP | |||
| CPAP/ASV | 16/15 | 0/0 | — |
| Medications | |||
| β‐Blocker | 27 (87.1) | 58 (74.4) | 0.148 |
| RAS inhibitor | 29 (93.5) | 63 (80.8) | 0.097 |
| Diuretic | 10 (32.3) | 42 (53.8) | 0.042 |
| Aldosterone antagonist | 13 (41.9) | 35 (44.9) | 0.781 |
| Statin | 12 (38.7) | 19 (24.4) | 0.134 |
Abbreviations: AF, atrial fibrillation; ASV, adaptive servo ventilation; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; DM, diabetes mellitus; NYHA, New York Heart Association; PAP, positive airway pressure; RAS, renin‐angiotensin‐aldosterone; SD, standard deviation.
Data are presented as mean ± SD or n (%).